Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Scribe Therapeutics Inc. SCTX

Full chart Compare
Set alert

Price alert · SCTX

All alert types
16.03 USD +0.55 (+3.55%)

Nov 6, 2026, 10:43 AM EST

15.29 Day range 16.44
13.50 52-week range 39.60
YTD
-15.50%
1 year
-15.50%

Revenue & Expenses

Other Income → Expenses: $4.85MIncome Tax Benefit → Expenses: $1.80MExpenses → Selling, General & Admin: $16.45MExpenses → Research & Development: $60.80MExpenses → Interest Expense: $2.39MGross Profit → Expenses: $51.17MRevenue → Gross Profit: $51.17MNet Loss → Expenses: $21.81MOther Income$4.85MIncome Tax Benefit$1.80MGross Profit$51.17MNet Loss$21.81MExpenses$79.64MSelling, General & Admin$16.45MResearch & Development$60.80MInterest Expense$2.39MRevenue$51.17M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
SCTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
51.17M27.41M
51.17M27.41M
-26.07M-42.83M
-21.81M-47.79M
-1.52-3.37

Balance sheet

Full balance sheet How to read it
SCTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
13.47M13.28M
78.22M127.97M
101.28M133.47M
41.43M41.68M
-143.42M-125.86M

Cash flow

Full cash flow How to read it
SCTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-45.21M-45.23M
45.27M13.01M
142.00K-222.00K
-1.27M-1.35M
194.00K-32.44M